Allkem, Livent Secure All Required Regulatory Approvals Globally To Close Merger Of Equals; Target Closing Of Transaction On January 4, 2024
Author: Benzinga Newsdesk | November 14, 2023 04:26pm
This includes antitrust approvals in Canada, China, Japan, South Korea and the U.S., as well as completion of investment screenings in Australia, the U.K. and the U.S. The closing of the Transaction remains subject to approval by both Livent and Allkem shareholders, and Australian Court approval of the Scheme.
Posted In: LTHM